Aberdeen Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Aberdeen Asset Management's JNJ Position: Q2 2017 in Review
Aberdeen Asset Management reduced its Johnson & Johnson (JNJ) stake by 9.8% in Q2 2017, selling an estimated $51.8M and leaving 3,740,467 shares worth $495M. The position accounts for 1.65% of the portfolio, ranked #9.
Aberdeen Asset Management first reported a position in JNJ in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.68B in Q3 2014. 2,350 funds tracked by Wall St. Rank hold JNJ as of Q2 2017.
- Aberdeen Asset Management held 3,740,467 shares of Johnson & Johnson worth $495M as of Q2 2017.
- Aberdeen Asset Management sold 406,257 Johnson & Johnson shares in Q2 2017, an estimated $51.8M.
- Johnson & Johnson made up 1.65% of Aberdeen Asset Management's portfolio in Q2 2017, its #9 holding.
- Aberdeen Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 17 quarters since.
- Aberdeen Asset Management's Johnson & Johnson position peaked at $1.68B in Q3 2014.
- 2,350 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2017.
Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.